MedTrace Logo

Tertiary Care for Visual Developmental Disorders in Pre-school Children

NCT03251456 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1114

Last updated 2019-06-20

No results posted yet for this study

Summary

Visual development disorders are major public health problems among children especially in China. How to find an effective and economic way to manage the larger number of children in China remains exploring. The national basic public health services of China offer visual acuity screening for preschool children for free every year. The aim of this study is to demonstrate the feasibility, cost-effective and the influence factors of compliance of tertiary care for visual developmental disorders in pre-school children after screening, and whether this disease management model is more effective and superior than the current medical care in china.

Conditions

  • Visual Developmental Disorders

Interventions

OTHER

Tertiary care

1. Inform the parents that there are abnormalities after eye disease screening of their children, and the program of tertiary care for visual developmental disorders 2. The children will be receiving the appropriate therapy in tertiary care and follow-up according to the clinical guidelines 3. Six months after receiving the screening report, all the parents will be interviewed by telephone, or visiting if necessary.

OTHER

Usual Care

1. Inform the parents that there are abnormalities after eye disease screening of their children 2. Inform the parents that they should take their children to the hospital for further consultation 3. Six months after the receiving the screening report, all the parents will be interviewed by telephone, or visiting if necessary.

Sponsors & Collaborators

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Yizhi LIU, MD,PhD · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Yangfa ZENG, MD,Master · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-18
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03251456 on ClinicalTrials.gov